{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:52:02Z","timestamp":1791345122978,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BO1573"],"award-info":[{"award-number":["BO1573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Melanoma cells exhibit elevated translation activity and rely on intact ribosomes to sustain their high protein synthesis demand. To support this process, efficient ribosome biogenesis is essential. RSL24D1 is a ribosome biogenesis factor required for late-stage maturation of the 60S ribosomal subunit. By ensuring correct ribosomal assembly, RSL24D1 supports global protein translation and maintains cellular homeostasis. Transcript and protein analyses revealed that RSL24D1 is upregulated in melanoma cells compared to normal human epidermal melanocytes. This overexpression correlates with reduced patient survival, suggesting an oncogenic role. Reduction of RSL24D1 expression impaired protein synthesis, decreased cell growth and resulted in the accumulation of unincorporated ribosomal proteins RPL5 and RPL11, which form the 5S RNP complex and inhibit the binding of MDM2 to p53. This inhibition stabilised p53 and activated downstream targets, including\n                    <jats:italic>CDKN1A<\/jats:italic>\n                    , resulting in G1 phase arrest and a senescence-like phenotype. These findings identify RSL24D1 as a critical component linking ribosome biogenesis to the p53 stress response. Targeting RSL24D1 creates a translational bottleneck, suppressing cell growth in p53 wild-type and p53-mutant cancer cells, highlighting it as a potential therapeutic target.\n                  <\/jats:p>","DOI":"10.1038\/s41417-026-01089-6","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:39:56Z","timestamp":1791344396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RSL24D1 links ribosome biogenesis to p53 activation in melanoma"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9136-4567","authenticated-orcid":false,"given":"Leonie","family":"Stahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3772-477X","authenticated-orcid":false,"given":"Sebastian","family":"Staebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8147-394X","authenticated-orcid":false,"given":"Anja K.","family":"Bosserhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"1089_CR1","volume":"13","author":"MG Davey","year":"2021","unstructured":"Davey MG, Miller N, McInerney NM. A review of epidemiology and cancer biology of malignant melanoma. Cureus. 2021;13:e15087.","journal-title":"Cureus"},{"key":"1089_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03220-9","volume":"24","author":"M-Y Hsieh","year":"2024","unstructured":"Hsieh M-Y, Hsu S-K, Liu T-Y, Wu C-Y, Chiu C-C. Melanoma biology and treatment: a review of novel regulated cell death-based approaches. Cancer Cell Int. 2024;24:63.","journal-title":"Cancer Cell Int"},{"key":"1089_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/pcmr.12391","volume":"28","author":"GR Kardos","year":"2015","unstructured":"Kardos GR, Robertson GP. Therapeutic interventions to disrupt the protein synthetic machinery in melanoma. Pigment Cell Melanoma Res. 2015;28:501\u201319.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1089_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcae017","volume":"6","author":"S-P Hwang","year":"2024","unstructured":"Hwang S-P, Denicourt C. The impact of ribosome biogenesis in cancer: from proliferation to metastasis. NAR Cancer. 2024;6:zcae017.","journal-title":"NAR Cancer"},{"key":"1089_CR5","doi-asserted-by":"crossref","unstructured":"Gitareja K, Chelliah SS, Sanij E, Sandhu S, Kang J, Khot A. Ribosome biogenesis and function in cancer: from mechanisms to therapy. Cancers. 2025;17:2534.","DOI":"10.3390\/cancers17152534"},{"key":"1089_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36037-7","volume":"14","author":"S Durand","year":"2023","unstructured":"Durand S, Bruelle M, Bourdelais F, Bennychen B, Blin-Gonthier J, Isaac C, et al. RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells. Nat Commun. 2023;14:356.","journal-title":"Nat Commun"},{"key":"1089_CR7","unstructured":"The Human Protein Atlas consortium. The Human Protein Atlas: https:\/\/www.proteinatlas.org; 2025."},{"key":"1089_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1083\/jcb.201205021","volume":"199","author":"L Kappel","year":"2012","unstructured":"Kappel L, Loibl M, Zisser G, Klein I, Fruhmann G, Gruber C, et al. Rlp24 activates the AAA-ATPase Drg1 to initiate cytoplasmic pre-60S maturation. J Cell Biol. 2012;199:771\u201382.","journal-title":"J Cell Biol"},{"key":"1089_CR9","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.celrep.2018.01.056","volume":"22","author":"KI Farley-Barnes","year":"2018","unstructured":"Farley-Barnes KI, McCann KL, Ogawa LM, Merkel J, Surovtseva YV, Baserga SJ. Diverse regulators of human ribosome biogenesis discovered by changes in nucleolar number. Cell Rep. 2018;22:1923\u201334.","journal-title":"Cell Rep"},{"key":"1089_CR10","doi-asserted-by":"crossref","unstructured":"Staebler S, Hoechst S, Thongmao A, Schneider N, Bosserhoff A-K, Kuphal S. The role of T-cadherin (CDH13) in treatment options with garcinol in melanoma. Cancers. 2024;16:1853.","DOI":"10.3390\/cancers16101853"},{"key":"1089_CR11","doi-asserted-by":"crossref","unstructured":"L\u00e4mmerhirt L, Kappelmann-Fenzl M, Fischer S, Pommer M, Zimmermann T, Kluge V, et al. Knockdown of lamin B1 and the corresponding lamin B receptor leads to changes in heterochromatin state and senescence induction in malignant melanoma. Cells 2022;11:2154.","DOI":"10.3390\/cells11142154"},{"key":"1089_CR12","doi-asserted-by":"crossref","unstructured":"Zimmermann T, Pommer M, Kluge V, Chiheb C, Muehlich S, Bosserhoff A-K. Detection of cellular senescence in human primary melanocytes and malignant melanoma cells in vitro. Cells 2022;11:1489.","DOI":"10.3390\/cells11091489"},{"key":"1089_CR13","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.18632\/oncotarget.13585","volume":"8","author":"AK Bosserhoff","year":"2017","unstructured":"Bosserhoff AK, Schneider N, Ellmann L, Heinzerling L, Kuphal S. The neurotrophin Neuritin1 (cpg15) is involved in melanoma migration, attachment-independent growth, and vascular mimicry. Oncotarget. 2017;8:1117\u201331.","journal-title":"Oncotarget"},{"key":"1089_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1600-0625.2011.01271.x","volume":"20","author":"AK Bosserhoff","year":"2011","unstructured":"Bosserhoff AK, Ellmann L, Kuphal S. Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma. Exp Dermatol. 2011;20:435\u201340.","journal-title":"Exp Dermatol"},{"key":"1089_CR15","doi-asserted-by":"crossref","unstructured":"Staebler S, Lichtblau A, Gurbiel S, Schubert T, Riechers A, Rottensteiner-Brandl U, et al. MIA\/CD-RAP regulates MMP13 and is a potential new disease-modifying target for osteoarthritis therapy. Cells 2023;12:229.","DOI":"10.3390\/cells12020229"},{"key":"1089_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018;28:436\u201353.","journal-title":"Trends Cell Biol"},{"key":"1089_CR17","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/j.febslet.2014.04.014","volume":"588","author":"L Golomb","year":"2014","unstructured":"Golomb L, Volarevic S, Oren M. p53 and ribosome biogenesis stress: the essentials. FEBS Lett. 2014;588:2571\u20139.","journal-title":"FEBS Lett"},{"key":"1089_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1261\/rna.079149.122","volume":"29","author":"MA McCool","year":"2022","unstructured":"McCool MA, Buhagiar AF, Bryant CJ, Ogawa LM, Abriola L, Surovtseva YV, et al. Human pre-60S assembly factors link rRNA transcription to pre-rRNA processing. RNA. 2022;29:82\u201396.","journal-title":"RNA"},{"key":"1089_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2022.03.043","volume":"136","author":"C Ni","year":"2023","unstructured":"Ni C, Buszczak M. The homeostatic regulation of ribosome biogenesis. Semin Cell Dev Biol. 2023;136:13\u201326.","journal-title":"Semin Cell Dev Biol"},{"key":"1089_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature10912","volume":"485","author":"AC Hsieh","year":"2012","unstructured":"Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012;485:55\u201361.","journal-title":"Nature"},{"key":"1089_CR21","doi-asserted-by":"crossref","unstructured":"Ruggero D. Translational control in cancer etiology. Cold Spring Harb Perspect Biol 2013;5:a012336.","DOI":"10.1101\/cshperspect.a012336"},{"key":"1089_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112699","volume":"42","author":"K D\u00f6rner","year":"2023","unstructured":"D\u00f6rner K, Ruggeri C, Zemp I, Kutay U. Ribosome biogenesis factors-from names to functions. EMBO J. 2023;42:e112699.","journal-title":"EMBO J"},{"key":"1089_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","volume":"18","author":"J Pelletier","year":"2018","unstructured":"Pelletier J, Thomas G, Volarevi\u0107 S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer. 2018;18:51\u201363.\u00a0","journal-title":"Nat Rev Cancer"},{"key":"1089_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.tig.2022.02.010","volume":"38","author":"PL Vaddavalli","year":"2022","unstructured":"Vaddavalli PL, Schumacher B. The p53 network: cellular and systemic DNA damage responses in cancer and aging. Trends Genet. 2022;38:598\u2013612.","journal-title":"Trends Genet"},{"key":"1089_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, et al. A landscape of driver mutations in melanoma. Cell. 2012;150:251\u201363.","journal-title":"Cell"},{"key":"1089_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ijc.2910550407","volume":"55","author":"JS Castresana","year":"1993","unstructured":"Castresana JS, Rubio MP, V\u00e1zquez JJ, Idoate M, Sober AJ, Seizinger BR, et al. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer. 1993;55:562\u20135.","journal-title":"Int J Cancer"},{"key":"1089_CR27","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/onc.2016.472","volume":"36","author":"C Worrall","year":"2017","unstructured":"Worrall C, Suleymanova N, Crudden C, Trocoli Drakensj\u00f6 I, Candrea E, Nedelcu D, et al. Unbalancing p53\/Mdm2\/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma. Oncogene. 2017;36:3274\u201386.","journal-title":"Oncogene"},{"key":"1089_CR28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1101\/gad.7.7a.1126","volume":"7","author":"X Wu","year":"1993","unstructured":"Wu X, Bayle JH, Olson D, Levine AJ. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 1993;7:1126\u201332.","journal-title":"Genes Dev"},{"key":"1089_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/387299a0","volume":"387","author":"MH Kubbutat","year":"1997","unstructured":"Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature. 1997;387:299\u2013303.","journal-title":"Nature"},{"key":"1089_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.trecan.2016.03.002","volume":"2","author":"Y Liu","year":"2016","unstructured":"Liu Y, Deisenroth C, Zhang Y. RP-MDM2-p53 pathway: linking ribosomal biogenesis and tumor surveillance. Trends Cancer. 2016;2:191\u2013204.","journal-title":"Trends Cancer"},{"key":"1089_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tips.2025.02.001","volume":"46","author":"GC Howard","year":"2025","unstructured":"Howard GC, Tansey WP. Ribosome-directed cancer therapies: the tip of the iceberg? Trends Pharm Sci. 2025;46:303\u201310.","journal-title":"Trends Pharm Sci"},{"key":"1089_CR32","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1158\/0008-5472.CAN-11-3992","volume":"72","author":"G Donati","year":"2012","unstructured":"Donati G, Montanaro L, Derenzini M. Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res. 2012;72:1602\u20137.","journal-title":"Cancer Res"},{"key":"1089_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.108774","volume":"700","author":"J-F Tang","year":"2021","unstructured":"Tang J-F, Li G-L, Zhang T, Du Y-M, Huang S-Y, Ran J-H, et al. Homoharringtonine inhibits melanoma cells proliferation in vitro and vivo by inducing DNA damage, apoptosis, and G2\/M cell cycle arrest. Arch Biochem Biophys. 2021;700:108774.","journal-title":"Arch Biochem Biophys"},{"key":"1089_CR34","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1124\/pharmrev.123.001026","volume":"76","author":"W Wang","year":"2024","unstructured":"Wang W, Albadari N, Du Y, Fowler JF, Sang HT, Xian W, et al. MDM2 inhibitors for cancer therapy: the past, present, and future. Pharmacol Rev. 2024;76:414\u201353.","journal-title":"Pharmacol Rev"},{"key":"1089_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103636","volume":"9","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wen X, Peng R, Pan Q, Weng D, Ma Y, et al. A first-in-human phase I study of a novel MDM2\/p53 inhibitor alrizomadlin in advanced solid tumors. ESMO Open. 2024;9:103636.","journal-title":"ESMO Open"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01089-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:39:58Z","timestamp":1791344398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01089-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":35,"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01089-6","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Sampling and handling of human tissue material were carried out in accordance with the ethical principles of the Declaration of Helsinki. The use of human tissue material was approved by the local ethics committee of the University of Regensburg (application numbers 09\/11 and 03\/151).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}